Everly Bio

Fertility Care with Molecular Platform

Health Tech & Life Sciences
Active
Pre-Seed Jerusalem, Israel Founded 2023
Total raised
$1.7M
Stage
Pre-Seed
Founded
2023
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Everly Bio harnesses novel multisystem molecular insights and advanced computational biology for unprecedented decision support in fertility. Infertility is a growing global issue, that affects 1 in 6 couples. The demand for fertility services has reached unprecedented levels. However, the market has been slow to innovate, with current solutions being ineffective. Everly Bio aims to revolutionize the methodology of infertility treatments, enabling shorter time to pregnancy, increasing accessibility. Combining noninvasive technology with molecular insights and AI. Our solution serves as a platform for diagnosis and intervention.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
BiologicalsArtificial Intelligence
Target customers
Healthcare & Life SciencesConsumers
Business model
B2CB2B

Highlights

Verified

Tags

healthcarefertilityartificial-intelligencemachine-learningfemtech